| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.2201 | 33 |
| GSM780708 | Untreated after 4 days (C2_1) | 39.8707 | 6 |
| GSM780709 | Untreated after 4 days (C3_1) | 39.2375 | 5 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.9168 | 22 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.1352 | 37 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.1328 | 23 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 40.3913 | 8 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.0522 | 22 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.6298 | 16 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 35.2062 | 1 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.6402 | 40 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.9187 | 22 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.1235 | 23 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.0474 | 22 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.3627 | 38 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.3725 | 43 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.3095 | 24 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.729 | 51 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.8638 | 21 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.5902 | 43 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 39.2724 | 5 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.5642 | 35 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.7949 | 31 |